Back to search

Boston University

Modeling myasthenia gravis with an optogenetic neuromuscular platform: evaluation of a new drug

Abstract

dc:description.abstract

Myasthenia gravis (MG) is an autoimmune disease characterized by muscle weakness caused by deterioration of the neuromuscular junction (NMJ). MG autoantibodies typically target acetylcholine receptor (AChR) proteins in the NMJ, blocking their function, causing their internalization and turnover, or damaging the cell through the complement protein cascade. The purpose of this study is to recapitulate the pathophysiology of MG using an in vitro human 3D optogenetic NMJ model, evaluate functional changes due to MG patient serum, and to test the efficacy of a complement protein inhibitor. Understanding the morphological and functional changes caused by various patient sera and their antibodies will assist in evaluating the inhibitor and help design future treatments for MG. This study showed that MG patient sera decreased NMJ function significantly in the model and demonstrated that the complement inhibitor was effective at protecting NMJ function when used prophylactically.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Liberman, Martin
Advisors dc:contributor.advisor
  • Chen, Christopher
  • Vunjak-Novakovic, Gordana

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • Attribution 4.0 International
Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/45594

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Liberman, Martin. Modeling myasthenia gravis with an optogenetic neuromuscular platform: evaluation of a new drug. masters thesis, Boston University, 2022. https://hdl.handle.net/2144/45594